Highlights from the 2016 North American Cystic Fibrosis Conference.

about

Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients

P2860

Q55212210-F764136C-58CC-47AF-B346-CD0DCFD73BDB Q58700574-DBC7AB69-8AA9-4E2A-972D-4E5B6375EAE9

P2860

Highlights from the 2016 North American Cystic Fibrosis Conference.

Item

http://www.wikidata.org/entity/Q38684319

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Highlights from the 2016 North American Cystic Fibrosis Conference.

@en

type

Item

label

Highlights from the 2016 North American Cystic Fibrosis Conference.

@en

prefLabel

Highlights from the 2016 North American Cystic Fibrosis Conference.

@en

P1476

Highlights from the 2016 North American Cystic Fibrosis Conference

@en

P2093

BreAnna Kinghorn

http://www.w3.org/2001/XMLSchema#string

Charles R Esther

http://www.w3.org/2001/XMLSchema#string

Cori L Daines

http://www.w3.org/2001/XMLSchema#string

Elisabeth P Dellon

http://www.w3.org/2001/XMLSchema#string

Marianne S Muhlebach

http://www.w3.org/2001/XMLSchema#string

Thida Ong

http://www.w3.org/2001/XMLSchema#string

P2860

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

OPTN/SRTR 2015 Annual Data Report: Lung.

Cystic fibrosis since 1938.

Cystic fibrosis: a model system for precision medicine.

Impact of the lung allocation score.

Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.

An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.

P304

1103-1110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PPUL.23707

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Edith T Zemanick

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696526

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

5963883

http://www.w3.org/2001/XMLSchema#string

Highlights from the 2016 North American Cystic Fibrosis Conference.

about

P2860

P2860

Highlights from the 2016 North American Cystic Fibrosis Conference.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932